TCL Archive NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups. January 12, 2007
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976